United States · FDA National Drug Code directory
Cladribine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-8201_549c44bf-67d2-9e14-e063-6294a90a9097
- Product NDC
- 0781-8201
- Form
- TABLET
- Composition / generic term
- Cladribine
- Labeler
- Sandoz Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260429
- Source listing expiry
- 20271231
Source-listed ingredients
- CLADRIBINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 TABLET in 1 CARTON (0781-8201-37) · 0781-8201-37
- 5 TABLET in 1 CARTON (0781-8201-51) · 0781-8201-51
- 6 TABLET in 1 CARTON (0781-8201-68) · 0781-8201-68
- 7 TABLET in 1 CARTON (0781-8201-71) · 0781-8201-71
- 10 TABLET in 1 CARTON (0781-8201-80) · 0781-8201-80
- 8 TABLET in 1 CARTON (0781-8201-85) · 0781-8201-85
- 4 TABLET in 1 CARTON (0781-8201-94) · 0781-8201-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →